AccueilBCRX • NASDAQ
add
BioCryst Pharmaceuticals
Dernière clôture
6,67 $
Variation sur la journée
6,60 $ - 6,73 $
Plage sur l'année
6,00 $ - 11,31 $
Capitalisation boursière
1,40 Md USD
Volume moyen
4,18 M
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
NASDAQ
Actualités
À propos
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Date de fondation
1986
Siège social
Site Web
Employés
580
